Literature DB >> 8897578

The management of renal osteodystrophy.

I B Salusky1, W G Goodman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8897578     DOI： 10.1007/s004670050183

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  18 in total

Review 1.  Renal osteodystrophy.

Authors:  D J Sherrard
Journal:  Semin Nephrol       Date:  1986-03       Impact factor: 5.299

2.  Optimal correction of acidosis changes progression of dialysis osteodystrophy.

Authors:  A Lefebvre; M C de Vernejoul; J Gueris; B Goldfarb; A M Graulet; C Morieux
Journal:  Kidney Int       Date:  1989-12       Impact factor: 10.612

3.  Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism.

Authors:  H Reichel; A Szabo; J Uhl; S Pesian; A Schmutz; H Schmidt-Gayk; E Ritz
Journal:  Kidney Int       Date:  1993-12       Impact factor: 10.612

4.  Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function.

Authors:  G Hercz; Y Pei; C Greenwood; A Manuel; C Saiphoo; W G Goodman; G V Segre; S Fenton; D J Sherrard
Journal:  Kidney Int       Date:  1993-10       Impact factor: 10.612

5.  Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.

Authors:  I B Salusky; J A Ramirez; W Oppenheim; B Gales; G V Segre; W G Goodman
Journal:  Kidney Int       Date:  1994-01       Impact factor: 10.612

6.  Intravenous versus oral calcitriol therapy in renal osteodystrophy: results of a prospective, pulsed and dose-comparable study.

Authors:  S Mazzaferro; M Pasquali; P Ballanti; E Bonucci; P Di Sanza; D Sardella; F Taggi; G Coen
Journal:  Miner Electrolyte Metab       Date:  1994

7.  The spectrum of bone disease in end-stage renal failure--an evolving disorder.

Authors:  D J Sherrard; G Hercz; Y Pei; N A Maloney; C Greenwood; A Manuel; C Saiphoo; S S Fenton; G V Segre
Journal:  Kidney Int       Date:  1993-02       Impact factor: 10.612

8.  Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.

Authors:  I B Salusky; J W Coburn; J Brill; J Foley; E Slatopolsky; R N Fine; W G Goodman
Journal:  Kidney Int       Date:  1988-05       Impact factor: 10.612

9.  The effects of intraperitoneal calcitriol on calcium and parathyroid hormone.

Authors:  J A Delmez; C S Dougan; B K Gearing; M Rothstein; D W Windus; N Rapp; E Slatopolsky
Journal:  Kidney Int       Date:  1987-03       Impact factor: 10.612

10.  Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease.

Authors:  I B Salusky; J Foley; P Nelson; W G Goodman
Journal:  N Engl J Med       Date:  1991-02-21       Impact factor: 91.245
View more
  4 in total

Review 1.  Dialysis therapy in end-stage renal disease.

Authors:  A Kalia
Journal:  Indian J Pediatr       Date:  1999 Mar-Apr       Impact factor: 1.967

2.  Parathyroid hormone and its fragments in children with chronic renal failure.

Authors:  Simon Waller; Anthony Reynolds; Deborah Ridout; Tom Cantor; Ping Gao; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2003-10-24       Impact factor: 3.714

3.  Intermittent or daily administration of 1-alpha calcidol for nephrectomised infants on peritoneal dialysis?

Authors:  Tuure T Saarinen; Pekka Arikoski; Christer Holmberg; Kai Rönnholm
Journal:  Pediatr Nephrol       Date:  2007-09-13       Impact factor: 3.714

4.  Catch-up growth with normal parathyroid hormone levels in chronic renal failure.

Authors:  Simon Waller; Sarah Ledermann; Richard Trompeter; William van't Hoff; Deborah Ridout; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2003-10-30       Impact factor: 3.714
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.